Not only does our environment influence our mental and physical health, it can also change the functioning of the genes we inherit at birth

Directed by Natalie Grizenko, MD, and Ridha Joober, MD, PhD, the laboratory studies the genetic and pharmacogenetic aspects of psychiatric disorders such as schizophrenia, ADHD and eating disorders.

Directed by Thomas Brown, PhD, and Christine Gianoulakis, PhD, the laboratory is researching the genetic etiology and underlying mechanisms of addiction as well as the markers of predisposition to addiction.

Aurélie Labbe is a biostatistician who specializes in statistical genetics and genetic epidemiology.

Florian Storch explores explores the biological role of circadian clocks, internal timers that generate rhythms  of 24 hours.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Reut Gruber examines the association between sleep and attention in children and adolescents and the genetics of sleep.

Her current research interests lie in the areas of molecular genetic and personality factors that influence eating disorder symptoms and treatment outcomes.